TRISS as a Predictor of Trauma Patient Outcomes (NCT06711536) | Clinical Trial Compass
CompletedNot Applicable
TRISS as a Predictor of Trauma Patient Outcomes
Iraq204 participantsStarted 2024-11-15
Plain-language summary
The goal of this prospective observational study is to evaluate the predictive utility of the Trauma and Injury Severity Score (TRISS) in determining patient outcomes, including survival and mortality, among trauma patients admitted to the trauma and emergency department of Kadhimiya Educational Hospital, Iraq.
The main questions it aims to answer are:
How accurately does TRISS predict survival and mortality outcomes in trauma patients? What is the performance of TRISS in predicting secondary outcomes, such as the need for intensive care, surgical interventions, and length of hospital stay?
Participants will:
Be assessed using the TRISS score upon their admission to the emergency department.
Have their clinical outcomes, including survival, need for intensive care, surgery, and hospital stay, monitored throughout their hospitalization.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Trauma patients admitted to the emergency department of Al-Kadhimiya Teaching Hospital.
* Patients with adequate documentation of physiological and anatomical data are required for TRISS calculation.
* Trauma scoring (TRISS) completed within the first 6 hours of hospital arrival to ensure timely assessment.
Exclusion Criteria:
* Patients under 18 years, pregnant women, or those with conditions that alter standard trauma scoring or management.
* Non-trauma cases (e.g., medical emergencies, terminal illnesses) to ensure focus on trauma-specific outcomes.
* Patients with incomplete or missing data required for TRISS calculation.
* Patients declared dead on arrival or those not treated in the trauma and emergency department.
* Individuals refusing participation or withdrawing consent at any stage of the study.
* Patients transferred to or from another facility or enrolled in other studies that might affect scoring accuracy or outcomes.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Accuracy Assessment of TRISS in Predicting In-Hospital Mortality
Timeframe: From admission to hospital discharge or death, up to 30 days.
2
Accuracy Assessment of TRISS in Predicting the Need for Intervention
Timeframe: From admission to hospital discharge or death, up to 30 days.
3
Accuracy Assessment of TRISS in Predicting the Need for Endotracheal Intubation
Timeframe: From emergency department admission to intubation, discharge, or in-hospital death, up to 30 days.
4
Accuracy Assessment of TRISS in Predicting Length of Hospitalization
Timeframe: From hospital admission to discharge, up to 30 days.